Liu LW - Search Results

1

A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma.

He YZ, He K, Huang RQ, Liu LW, Ye SW, Qian JL, Peng P, Luo QJ, Wang ZL, Hu ZM. He YZ, et al. Among authors: liu lw. Sci Rep. 2021 Apr 15;11(1):8275. doi: 10.1038/s41598-021-87782-y. Sci Rep. 2021. PMID: 33859298 Free PMC article.

2

Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis.

He YZ, He K, Huang RQ, Wang ZL, Ye SW, Liu LW, Luo QJ, Hu ZM. He YZ, et al. Among authors: liu lw. Ann Hepatol. 2020 Nov-Dec;19(6):654-661. doi: 10.1016/j.aohep.2020.07.002. Epub 2020 Aug 5. Ann Hepatol. 2020. PMID: 32768591 Free article.

3

A novel simple risk model to predict the prognosis of patients with paraquat poisoning.

Gao Y, Liu L, Li T, Yuan D, Wang Y, Xu Z, Hou L, Zhang Y, Duan G, Sun C, Che L, Li S, Sun P, Li Y, Ren Z. Gao Y, et al. Sci Rep. 2021 Jan 8;11(1):237. doi: 10.1038/s41598-020-80371-5. Sci Rep. 2021. PMID: 33420265 Free PMC article.

4

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.

Zhang Y, Liu X, Liu L, Chen J, Hu Q, Shen S, Zhou Y, Chen S, Xue C, Cui G, Yu Z. Zhang Y, et al. Dis Markers. 2020 Jan 13;2020:2514090. doi: 10.1155/2020/2514090. eCollection 2020. Dis Markers. 2020. PMID: 32399086 Free PMC article.

5

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Hu Q, Shen S, Li J, Liu L, Liu X, Zhang Y, Zhou Y, Zhu W, Yu Y, Cui G. Hu Q, et al. Dis Markers. 2020 Jul 11;2020:3231273. doi: 10.1155/2020/3231273. eCollection 2020. Dis Markers. 2020. PMID: 32733617 Free PMC article.

6

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma.

Zhang J, Liu L, Wang Z, Hou M, Dong Z, Yu J, Sun R, Cui G. Zhang J, et al. Front Pharmacol. 2023 Apr 25;14:1172908. doi: 10.3389/fphar.2023.1172908. eCollection 2023. Front Pharmacol. 2023. PMID: 37180696 Free PMC article.

7

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma.

Rao B, Li J, Ren T, Yang J, Zhang G, Liu L, Wang H, Huang M, Ren Z, Yu Z. Rao B, et al. Front Cell Dev Biol. 2021 Jul 19;9:686547. doi: 10.3389/fcell.2021.686547. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34350180 Free PMC article.

8

Transcriptional analysis of the expression and prognostic value of lipid droplet-localized proteins in hepatocellular carcinoma.

Zhang Y, Liang X, Lian Q, Liu L, Zhang B, Dong Z, Liu K. Zhang Y, et al. BMC Cancer. 2023 Jul 18;23(1):677. doi: 10.1186/s12885-023-10987-z. BMC Cancer. 2023. PMID: 37464334 Free PMC article.

9

Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma.

Xue C, He Y, Zhu W, Chen X, Yu Y, Hu Q, Chen J, Liu L, Ren F, Ren Z, Cui G, Sun R. Xue C, et al. Am J Transl Res. 2018 Dec 15;10(12):4152-4162. eCollection 2018. Am J Transl Res. 2018. PMID: 30662658 Free PMC article.

10

Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes.

Liu L, Hu Q, Zhang Y, Sun X, Sun R, Ren Z. Liu L, et al. Front Pharmacol. 2023 Feb 22;14:1145408. doi: 10.3389/fphar.2023.1145408. eCollection 2023. Front Pharmacol. 2023. PMID: 36909154 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters